News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Crocs, Inc. announced record second-quarter results for 2026, with revenue reaching $1.2 billion, a 15% increase year-over-year. The company reported
This article announces that Amdocs (DOX) is scheduled to release its financial results after the market closes on August 05. It also provides key financial data for the company, including its market capitalization, enterprise value, and analysts' consensus estimates for its upcoming earnings and …
Crocs (NASDAQ:CROX) shares fell after the company provided a soft third-quarter outlook despite beating second-quarter earnings estimates. The company reported adjusted EPS of $4.55 and revenue of $1.179 billion, exceeding analyst expectations, and raised its full-year 2026 adjusted EPS and revenue guidance. However, its …
Crocs reported record sales in its latest quarter, driven by strong sandal sales and international growth. Despite this, the company's stock experienced a decline. The positive performance has led Crocs to increase its financial forecast for the upcoming period.
Crocs (CROX) reported strong Q2 2026 results, with adjusted earnings of $4.55 per share and revenues of $1.18 billion, both surpassing analyst estimates, driven by a significant 12% increase in direct-to-consumer (DTC) sales. Despite the positive financial performance and a raised full-year 2026 outlook, …
Crocs, Inc. has filed its unaudited quarterly report (Form 10-Q) for the period ended June 30, 2026, showing revenue growth to $1,179.5 million and net income of $204.9 million for the quarter. The report details share repurchases, with 2.3 million shares bought back for …
Crocs Inc. achieved a significant milestone, with its Crocs brand surpassing $1 billion in quarterly revenue for the first time, driven by strong DTC sales and international growth. While the Heydude brand experienced an overall revenue decline due to wholesale struggles, its DTC sales …
Crocs Inc. (Nasdaq: CROX) experienced a stock price decline in early trading despite reporting record revenues of nearly $1.18 billion in the second fiscal quarter of 2026, marking a 2.6% year-over-year increase and the Crocs Brand's first time surpassing $1 billion in quarterly revenue. …
As of March 2026, Crocs, Inc. (CROX) has approximately 8,024 employees worldwide, representing a 4.9% growth since 2023 but a 2.8% decline year-over-year in 2026. The company is actively hiring with 720 job postings in 2026, though new postings per month have decreased. Crocs' …
Crocs, Inc. has issued earnings guidance for the third quarter of 2026 and revised its full-year 2026 outlook upwards. The company anticipates third-quarter revenues to be approximately flat compared to 2025, while full-year revenues are projected to increase by 1% to 2% over 2025, …
Crocs Inc. reported strong second-quarter fiscal 2026 results, with consolidated revenues increasing by 2.6 percent to $1.179 billion and net income rising significantly. Despite beating analyst expectations for the quarter and raising full-year guidance, the company's shares dropped over 13 percent due to a …
Crocs, Inc. (CROX) reported strong Q2 2026 earnings, beating analyst estimates with an EPS of $4.55 and revenue of $1.18 billion. The flagship Crocs Brand achieved over $1 billion in quarterly revenue for the first time, leading management to raise full-year guidance and authorize …
Despite expectations for year-over-year earnings and revenue growth, recent analyst revisions for Amdocs (DOX) have become more cautious, with the most accurate EPS estimate slipping below the broader consensus. This divergence raises questions about Amdocs' ability to adhere to its guidance amidst ongoing client …
Amdocs (DOX) is projected to report a 7% year-over-year increase in earnings per share to $1.84 and a 2.7% rise in revenues to $1.18 billion for the quarter ended June 2026. However, its Zacks Earnings ESP of -0.65% combined with a Zacks Rank #2 …
Oculis Holding AG (NASDAQ: OCSAW) generated $1.51 million USD in revenue last year. The "Innovative Drug" segment was the top-performing segment, contributing $1.44 million USD, which represents an increase from $778.95K USD in the previous year. This indicates a significant revenue stream from its …
Crocs Inc. is set to announce its second-quarter earnings, with investors closely watching the performance of its Hey Dude brand for signs of a promised turnaround. Analysts are optimistic, with increasing EPS and revenue estimates, and several firms recently upgrading their price targets for …
Amdocs Ltd. (NASDAQ: DOX) had 26,688 employees worldwide as of March 2026, representing a 9.2% decline from 2023. Despite the overall reduction in workforce, Amdocs is actively hiring, with 350 active job postings in 2026. The company's workforce is concentrated in South Asia and …
Oculis Holding AG saw insiders offload CHF1.0m worth of stock over the past year, although a significant portion of these sales occurred at prices above the current market value. While long-term insider selling might raise concerns, recent insider buying totaling US$139k suggests some confidence …
OMERS Administration Corp significantly increased its stake in Crocs, Inc. (NASDAQ:CROX) by 31.9% in the first quarter, now holding 31,018 shares valued at $2.58 million. This comes as several institutional investors have adjusted their positions in the company, which also reported exceeding first-quarter earnings …
Dimensional Fund Advisors LP reduced its stake in Crocs, Inc. by 1.8% in the first quarter, although institutional investors collectively own a significant 93.44% of the company. Despite this sale and a recent sale by CEO Andrew Rees, analysts maintain a "Moderate Buy" rating …
This article provides key metrics for the Crocs, Inc. (CROX) bond CROX5146499, which has a 4.25% coupon rate and matures on March 15, 2029. The bond was issued on March 12, 2021, with an outstanding amount of $350 million USD. It also includes a …
This article provides a comprehensive timeline of historical dividend payouts for Amdocs Ltd (DOX), detailing interim and final cash dividends with their respective ex-dividend, record, and payment dates. It highlights that the company has distributed a total of 999.37 million USD in dividends over …
Tamar Rapaport Dagim, an insider at Amdocs Ltd. (NASDAQ: DOX), is planning to sell 12,780 Ordinary Shares through Oppenheimer & Co. Inc. on July 28, 2026, with an aggregate market value of $678,618.00. These shares were acquired on November 11, 2023, through the vesting …
Crocs Inc (CROX) has an institutional shareholding score of 10.00, placing it first in the Textiles & Apparel industry. The institutional shareholding proportion is 100.96%, despite an 18.80% quarter-over-quarter decrease. Li Lu is the largest institutional shareholder, holding 622.10K shares, representing 1.76% of shares …
Amdocs Ltd (DOX) has an institutional shareholding score of 10.00, placing it first in the Software & IT Services industry. Institutional shareholding stands at 98.79%, a 6.44% decrease quarter-over-quarter. Richard Pzena is the largest institutional shareholder, holding 13.50M shares, representing 11.79% of shares outstanding.
This article provides a detailed financial overview and market trends for Oculis Holding AG (OCS), a biotechnology company focused on eye disease treatments. It includes real-time stock quotes, key financial figures, analyst ratings indicating a "Strong Buy" with significant upside potential, and technical indicators …
The article discusses the revenue breakdown of Oculis Holding AG (OCS), noting that relevant data regarding business segments, regional revenue, and profit contributions have not yet been disclosed by the company. Despite the lack of detailed financial segments, the page provides current stock information, …
Oculis Holding AG (OCS) has received a "Strong Buy" rating from 12 analysts, with a target price of $39.80, representing a potential upside of 257.59%. The company's expected revenue for the next quarter is $235.59K, and its EPS for the previous quarter was -$0.53, …
This article provides a real-time analysis of Crocs Inc. (NASDAQ: CROX) stock movement, highlighting weak near-term sentiment but potential for mid and long-term shifts. It identifies key signals, support, and resistance levels, and offers three AI-generated trading strategies: Position Trading, Momentum Breakout, and Risk …
Analysts predict Crocs (CROX) will report Q2 earnings of $4.32 per share, a 2.1% year-over-year increase, with revenues projected at $1.15 billion, a slight decline of 0.2%. Key performance measures indicate an expected decline in HEYDUDE Brand revenues and a modest increase for the …
This article provides a detailed company profile for Crocs Inc. (CROX), including its business scope, financial data, and market performance. It highlights the company's brands, Crocs and HEYDUDE, and their proprietary footwear technologies and designs. The article also lists key company information, such as …
Search by ticker symbol or company name and select a result to open its chart.